Fat and/or wax activated by means of the water-insoluble fraction of carica papaya sap

ABSTRACT

The invention relates to a method for obtaining the water-insoluble fraction of  Carica papaya  sap, enriched with  Carica papaya  lipase, the water-insoluble fraction obtainable by this method, a method for the preparation of an activated fat and/or an activated wax by means of said water-insoluble fraction of the  Carica papaya  sap, the activated fat and/or the activated wax capable of being obtained by this method, a composition combining said activated fat and/or said activated wax, as well as the cosmetic use of these products.

RELATED APPLICATIONS

This application claims priority to U.S. Application No. 16,082,670,filed on Sep. 6, 2018, which is a national stage application ofPCT/EP2017/055350, filed on Mar. 7, 2017, which claims priority to FR1600394, filed on Mar. 8, 2016.

TECHNICAL FIELD

This invention relates to the field of cosmetics. More particularly, theinvention relates to activated fats and/or activated waxes administrableby dermal application/route, said activated fats and/or activated waxesbeing useful in cosmetics, in particular for delaying the appearance orlimiting signs of skin aging, protecting the skin and/or superficialbody surfaces against all types of external aggressions, and/orpromoting cell differentiation at the cutaneous level, or strengtheningthe barrier function of the skin and/or superficial body surfaces.

BACKGROUND OF THE INVENTION

The skin is a vital organ providing multiple functions such as sensoryand protective functions as well as immune, metabolic orthermoregulatory functions against multiple external aggressions(barrier function). These roles are made possible thanks to a structurein three distinct superimposed compartments: the epidermis, the dermisand the hypodermis. The epidermis is a surface epithelium thatconstitutes the outer structure of the skin and ensures its protectivefunction. This function is ensured by the cohesion of the epithelialcells and by the production of a filamentous and resistant protein,keratin. The dermis is a connective tissue made up of a fundamentalsubstance wherein fibroblasts, collagen fibers and elastin fibers,protein fibers synthesized by fibroblasts are bathed. The collagenfibers provide a large part of the strength of the dermis, theycontribute to the elasticity and especially to the tone of the skinand/or mucous membranes. Below the dermis is a layer of adipose tissue:the hypodermis.

The skin, like all other organs, is subject to aging. The factorsinvolved in the skin aging method are varied and numerous. Thephenomenon of chronological aging of the skin is accompanied, interalia, by a slowing down of cellular functions and the appearance ofstructural abnormalities in certain proteins of the extracellularmatrix. The skin becomes less supple, finer, often dry and it loses itselasticity, which is accompanied by wrinkles and fine lines.

In the epidermis, the slowing down of keratinocyte proliferation anddifferentiation with age is a factor that explains the thinning of theskin during aging. The epidermis atrophies, the skin loses itsprotective abilities. Dermal fibroblasts are also altered, and there isa decrease in the production of extracellular matrix proteins, such ascollagen or elastin.

Chronic exposure to ultraviolet and other aggressive environmentalfactors accelerates and aggravates the aging phenomenon of the skin. Weare speaking of photo-aging.

One of the mechanisms playing a major role in the aging method is theaccumulation of oxidative damage in essential molecules such as in lipidmembranes, proteins, DNA, and more particularly in mitochondrial DNA.Thus, one of the important consequences of the accumulation of thesedamages is a reduction in the ability of the cell to produce ATP.

For many years, health and cosmetic professionals have been looking forways to fight or, at least, to reduce the phenomena of skin aging, aswell as ways to increase the skin's resistance to external aggressionsand to the stress which it suffers daily.

In cosmetics, oils are the basis of the concept of natural cosmetics.Vegetable oils obtained through a natural treatment without the additionof synthetic chemicals are traditionally used for their properties ofhydration and protection.

Because of their specific composition, the oils most used in cosmeticsare oils composed of long-chain polyunsaturated acids, in particulargamma-linolenic acid, which plays a specific role in the fluidity ofmembranes, the reduction of trans-epidermal water losses, and theprevention of skin aging. Indeed, some fatty acids are likely to improveor maintain the degree of hydration of the skin.

Oils are most often used as an excipient and not as an activeingredient. However, the Applicant has previously developed acomposition, especially useful for cosmetic purposes, comprising, asactive ingredient, in a physiologically acceptable medium, at least thecombination of a specific diacylglycerol (abbreviated as “DAG”) and aparticular fatty alcohol. This composition is described and claimed inthe patent application PCT/FR2004/000944, published under the referenceWO 2004/093832 A2, in the name of the Applicant.

Diacylglycerols (DAG) are compounds specifically described in the PriorArt for their marker properties. They play a fundamental role, inparticular through the action they exert on a protein kinase C, and thushave the function of cellular activator.

As disclosed in patent application WO 2004/093832, the reaction methodto obtain DAGs may be a chemical reaction carried out in an acidic oralkaline medium such as, for example, the hydrolysis of triglyceridefats. This hydrolysis can also be carried out enzymatically, such as,for example, a biochemical reaction using a hydrolase such as a lipase.Preferably, the DAGs used in the compositions of WO 2004/093832 areobtained from fats (animal, vegetable or synthetic oils) comprisingtriglycerides having undergone enzymatic hydrolysis, specifically bylipases.

Lipases are enzymes that hydrolyze glycerol esters. Several types oflipase are determined according to their different reaction rate levels.These enzymes can also be classified into several groups, according totheir different specificities: with respect to the substrate; positionspecificity or regioselective; specificity with respect to the nature offatty acids or typo-selectivity; specificity with respect to a positionor stereospecificity.

Some lipases have no specific specificity. Others are regioselective:thus, for example, pancreatic lipase and lipases of microbial origin,Aspergillus, Rhysopus or Rhizomucor miehei are 1,3-selective lipases.Regioselective lipases are of common industrial use both in the fatindustry and in detergents. Other lipases are stereospecific, such asthe Candida lipase, which has a stereospecificity of the sn2 type. Thesn nomenclature determines the sn1, sn2 and sn3 positions of thetriglyceride skeleton according to the asymmetrical carbon configurationpresented in the Fisher projection.

In WO 2004/093832, a stereospecific lipase of the sn3 type (i.e., whichallows the hydrolysis of triglycerides in position 3) is advantageouslyused. This lipase thus hydrolyzes the triglycerides at the 3-position,preferentially forming 1,2-DAG. The lipase used may be of plant origin(Carica papaya) or microbial (Penicellium cyclopium). According to apreferred embodiment, the hydrolysis of the triglycerides is carried outin WO 2004/093832 with a lipase of Carica papaya (Villeneuve et al.,JAOCS, 72, 6:753.1995).

However, although the compositions obtained by implementing the teachingof patent application WO 2004/093832 have, in particular, satisfactorycosmetic properties at the cutaneous level, the Applicant has beenendeavoring, for more than ten years, to improve the method forpreparing these compositions, which method is exemplified in Example 1of WO 2004/093832. More specifically, and as indicated in this Example1, the enzymatic hydrolysis reaction to obtain 1,2-DAG is possible withraw papaya sap, however the use of a purified preparation of this sapafter solubilization in an aqueous medium, and with polyol orlyophilized preservation. Indeed, the method of preparation that is theobject of Example 1 of WO 2004/093832, if it works, there are a numberof practical difficulties. Indeed, with regard to the use of a rawpapaya sap, this is particularly disadvantageous in view of the factthat raw papaya sap contains not only the lipase of interest but alsoproteases (among which is papain, a protease cysteine) which are likelyto degrade the lipase or, at the very least, negatively impact itsenzymatic activity.

It is therefore logical that Example 1 of WO 2004/093832 favors the useof a purified preparation of this sap after solubilization in an aqueousmedium, preserved in a polyol (for example in sorbitol) or freeze-dried.Regarding the latter possibility, it is known to the man skilled in theart that lyophilizates present a number of disadvantages, among whichare their extreme sensitivity to atmospheric moisture and their complex(and therefore expensive) manufacturing method.

With regard to the technical solution of using a purified preparation ofpapaya sap after solubilization in an aqueous medium and preservation ina polyol (such as sorbitol), it turns out that this technique has theparticular disadvantage of requiring a complex treatment subsequent topartial hydrolysis of triglycerides. In fact, in order to stop thepartial hydrolysis reaction of the triglycerides, it is necessary tocarry out several washing steps of the aqueous medium containing theCarica papaya lipase preserved in the polyol, especially using organicsolvents.

Moreover, the Applicant has discovered that the Carica papaya lipasesolubilized in an aqueous medium and preserved in a polyol had undergonefreezing and, consequently, could barely—or even could not—be preservedin frozen form, whereas this is would be eminently desirable, with aview to ensuring good quality, convenient and inexpensive preservationof the Carica papaya lipase over time.

SUMMARY OF THE INVENTION

Through research, the Applicant has developed a real technologicalplatform to overcome all or part of the aforementioned drawbacks. Thistechnological platform is mainly based on obtaining and using thewater-insoluble (not soluble in water) fraction of the Carica papayasap. Consequently, the object of this invention is a method forobtaining the water-insoluble fraction of Carica papaya sap, enrichedwith Carica papaya lipase, said method comprising the following steps:

-   -   a) suspending dried raw Carica papaya sap in distilled water,        advantageously in a weight ratio of dried raw Carica        papaya/distilled water comprised of between about 0.01 and about        0.5 (preferably between 0.01 and 0.5), preferably between about        0.05 and about 0.25 (preferably between 0.05 and 0.25),        preferably between about 0.08 and about 0.2 (preferably between        0.08 and 0.2), and particularly preferably about 0.1 (preferably        0.1),    -   b) centrifuging the suspension obtained in step a) so as to        obtain a pellet containing said water-insoluble fraction of the        Carica papaya sap, advantageously for a time period comprised of        between about 5 minutes and about 90 minutes (preferably between        5 minutes and 90 minutes), preferably between about 15 and about        60 minutes (preferably between 15 minutes and 60 minutes),        preferably between about 20 and about 40 minutes (preferably        between 20 and 40 minutes), and advantageously at a rotational        speed comprised of between around 2000 and around 6000 rpm        (preferably between 2000 and 6000 rpm), preferably between        around 3000 and around 5000 rpm (preferably between 3000 and        5000 rpm), preferably around 4000 rpm (preferably 4000 rpm).    -   c) recovering the pellet containing said water-insoluble        fraction of the Carica papaya sap, enriched with Carica papaya        lipase.        -   In a particularly advantageous embodiment, said method            comprises, after step a) and before step b), the following            step:        -   a′) agitating the suspension obtained in step a) during a            time period comprised of between about 15 minutes and about            240 minutes (preferably between 15 minutes and 240 minutes),            advantageously for a time period of between about 30 minutes            and about 180 minutes (preferably between 30 minutes and 180            minutes), preferably between about 60 minutes and about 150            minutes (preferably between 60 minutes and 150 minutes), and            particularly preferably about 120 minutes (preferably 120            minutes), and at a temperature comprised of between about            10° C. and about 30° C. (preferably between 10° C. and 30°            C.), and at a temperature of between about 15° C. and about            25° C. (preferably between 15° C. and 25° C.), preferably at            room temperature.

By room temperature a temperature comprised of between about 20° C. andabout 25° C. is meant (preferably between 20° C. and 25° C.),advantageously a temperature of about 20° C. (preferably 20° C.)

Preferably, said method comprises, after step b) and before step c), thefollowing step:

-   -   b′) drying the wet pellet until a particulate powder is        obtained;    -   the water-insoluble fraction of Carica papaya sap, enriched with        Carica papaya lipase, being recovered in step c), in the form of        particulate powder.

Another object of the invention relates to the water-insoluble fractionof Carica papaya sap enriched with Carica papaya lipase, obtainable bythe aforementioned method.

The invention also relates to the water-insoluble fraction of Caricapapaya sap enriched with Carica papaya lipase, obtained directly by theabove method.

Particularly advantageously, the Applicant has discovered that thiswater-insoluble fraction of Carica papaya sap enriched with Caricapapaya lipase, could be preserved simply by freezing. In addition, themethod for obtaining this water-insoluble fraction of Carica papayalipase-enriched Carica papaya sap, is extremely simple to implement andinexpensive.

The invention also relates to the use of the water-insoluble fraction ofthe Carica papaya sap according to this invention for enriching a fatwith diacylglycerols (and thus obtaining an activated fat) and/or a waxwith fatty alcohols (and thus obtaining an activated wax).

Another object of the invention relates to a method for preparing adiacylglycerol-enriched fat (activated fat), said method comprising thefollowing steps:

-   -   i) mixing a fat with water or with a saline solution preferably        containing a divalent ion, such as a calcium or magnesium ion,        in a volume ratio of water or saline solution/fat comprised of        between about 0.005 and about 0.5 (preferably between 0.005 and        0.5), preferably between about 0.01 and about 0.4 (preferably        between 0.01 and 0.4),    -   ii) maintaining this mixture under agitation (preferably with        vigorous agitation, preferably at a speed of around 2000 to        around 3000 rpm (preferably from 2000 to 3000 rpm); said        vigorous agitation being advantageously obtained by means of an        apparatus promoting emulsions) until an emulsion is obtained        between the fat and water, at a temperature comprised of between        about 30° C. and about 70° C. (preferably between 30° C. and 70°        C.), advantageously about 50° C. (preferably 50° C.) preferably        during a time period comprised of between about 1 and about 30        minutes (preferably between 1 and 30 minutes), preferably        between about 5 and about 20 minutes (preferably between 5 and        20 minutes), and preferably about 10 minutes (preferably 10        minutes),    -   iii) continue under agitation (preferably with moderate        agitation, preferably at a speed of around 200 to around 300 rpm        [preferably 200 to 300 rpm]) and at said temperature, bringing        into contact the mixture obtained in the previous step with a        given volume of the water-insoluble fraction of Carica papaya        sap, enriched with Carica papaya lipase, obtained by        implementing the method for obtaining the water-insoluble        fraction of the above-mentioned Carica papaya sap, in a volume        ratio of the water-insoluble fraction of Carica papaya sap/fat        used comprised of between about 0.01 and about 0.2 (preferably        between 0.01 and 0.2), advantageously between about 0.05 and        0.015 (preferably between 0.05 and 0.015), preferably about 0.1        (preferably 0.1),    -   iv) maintaining said temperature and agitation for a time period        of from about one hour to approximately six hours (preferably        from one hour to six hours), advantageously from about two hours        to about five hours (preferably from two hours to five hours),        preferably for about four hours (preferably four hours), to        obtain the diacylglycerol-enriched fat.

In a particularly preferred embodiment, this method for preparing adiacylglycerol-enriched fat (activated fat) comprises, after step iv),the following step:

-   -   v) filtering the mixture obtained in step iv), preferably using        at least one gradient filter or at least one superposition of at        least two filters of decreasing porosity, advantageously from        around 500 μm to around 250 μm (preferably from 500 μm to 250        μm), so as to separate said water-insoluble fraction of Carica        papaya sap, enriched in Carica papaya lipase, from the reaction        medium containing the diacylglycerol-enriched fat.

Preferably, said method comprises, after step v), at least one of thefollowing two steps, and advantageously both:

-   -   removal of the residual water present in the reaction medium        containing the diacylglycerol-enriched fat by means of a drying        agent such as anhydrous magnesium sulphate, and/or    -   deodorizing and/or improving the shine of the        diacylglycerol-enriched fat by means of an activated carbon.

This filtration step v) makes it possible to easily stop the partialhydrolysis reaction of the triglycerides contained in the fat withoutrequiring a plurality of aqueous medium washing steps containing thelipase preserved in a polyol (as is the case with method of Example 1 ofWO 2004/093832) and to avoid the use of organic solvents. Following thisfiltration step v), the water-insoluble fraction Carica papaya sap isalso easily recovered and can be reused.

In general, the fact that is possible to use the water-insolublefraction of the Carica papaya sap obtained by means of theaforementioned production method makes the post-partial hydrolysishandling of the fat relatively easy. In addition, the Applicant hasdiscovered that the use of this water-insoluble fraction of the Caricapapaya lipase-enriched Carica papaya sap, would preserve unsaturatedfatty acids, which have advantageous cosmetic properties.

According to a particular embodiment, the water-insoluble fraction ofthe Carica papaya sap, enriched with Carica papaya lipase filtered instep v), is reused in step iii) of the method to prepare adiacylglycerol-enriched fat according to the invention.

Preferably, said fat is an animal, plant and/or marine origin oil,virgin or refined, advantageously virgin, said oil preferably being ofplant and/or marine origin, preferably of plant origin.

It is particularly important to note that using the water-insolublefraction of Carica papaya sap makes it possible for it to “work” with avirgin oil, namely to enrich (activate) a virgin oil withdiacylglycerols, which is particularly desirable for reasons of safetyand innocuousness (absence of organic solvents related to the refinementof oils etc.). In addition, the method for preparing adiacylglycerol-enriched fat according to the invention is particularlysuitable for the enrichment of virgin oils, insofar as theunsaponifiable fraction of the virgin oil is not deteriorated by saidmethod, the enzymatic activity used being of the triacylglycerolesterase type. This makes it possible to preserve the biologicalactivity of the virgin oils after the enrichment method withdiacylglycerols; this biological activity being further improved by saidmethod.

Preferably, said fat is an oil comprising triglycerides having:

-   -   aliphatic hydrocarbon chains of a fatty acid having a carbon        number of between 12 and 26, advantageously between 16 and 20,        and particularly preferably between 16 and 18; said aliphatic        hydrocarbon chain being linear or branched, advantageously        linear, saturated or unsaturated, advantageously unsaturated,        preferably with a number of unsaturations of between 1 and 6,        and preferably of between 1 and 3; or    -   mono- or polyhydroxylated and/or mono- or polymethoxylated        and/or mono- or polyoxidized and/or mono- or poly-epoxylated        chains.

According to a particularly preferred embodiment of this invention, anoil, preferably virgin is used as fat, selected from Calophylluminophyllum oil, raspberry oil, Camellia oil, evening primrose oil,Brazil nut oil, baobab oil and olive oil, or a mixture of at least twoof these oils; said oil, preferably virgin, being advantageouslyselected from Calophyllum inophyllum oil, raspberry oil, Camellia oil,evening primrose oil, Brazil nut oil, and baobab oil or a mixture of atleast two of these oils; said oil, preferably virgin, being preferablyselected from Calophyllum inophyllum oil, raspberry oil, eveningprimrose oil and baobab oil or a mixture of at least two of these oils;particularly preferably said fat being Calophyllum inophyllum oil,preferably virgin Calophyllum inophyllum oil.

The above diacylglycerols consist of 1,2-diacylglycerols and1,3-diacylglycerols

respectively represented by the following formulas (I) and (II):

wherein R1 and R2 are:

-   -   aliphatic hydrocarbon chains of a fatty acid having a carbon        number of between 12 and 26, advantageously between 16 and 20,        and particularly preferably between 16 and 18 (in other words R1        and R2 represent aliphatic hydrocarbon chains whose carbon        number is between 11 and 25, advantageously between 15 and 19,        and particularly preferably between 15 and 17); said aliphatic        hydrocarbon chain being linear or branched, advantageously        linear, saturated or unsaturated, advantageously unsaturated,        preferably with a number of unsaturations of between 1 and 6,        and preferably of between 1 and 3; or    -   mono- or polyhydroxylated, and/or mono- or polymethoxylated,        and/or mono- or polyoxidized, and/or mono- or poly-epoxylated        chains.

Preferably, said diacylglycerols comprise predominantly, and preferablyconsist essentially of, 1,2-diacylglycerols represented by the followingformula (I):

wherein R1 and R2 are:

-   -   aliphatic hydrocarbon chains of a fatty acid having a carbon        number of between 12 and 26, advantageously between 16 and 20,        and particularly preferably between 16 and 18 (in other words R1        and R2 represent aliphatic hydrocarbon chains whose carbon        number is between 11 and 25, advantageously between 15 and 19,        and particularly preferably between 15 and 17); said aliphatic        hydrocarbon chain being linear or branched, advantageously        linear, saturated or unsaturated, advantageously unsaturated,        preferably with a number of unsaturations of between 1 and 6,        and preferably of between 1 and 3; or    -   mono- or polyhydroxylated, and/or mono- or polymethoxylated,        and/or mono- or polyoxidized, and/or mono- or poly-epoxylated        chains.

The invention also relates to a method for preparing a fattyalcohol-enriched wax (activated wax), implementing the method forpreparing a diacylglycerol-enriched fat referred to above, by making thefollowing adaptations:

-   -   a wax is used as a fat; and    -   in the place of a diacylglycerol-enriched fat, a fatty        alcohol-enriched wax, advantageously fatty alcohols of formula        (III), is obtained:

R″—OH  (III)

wherein R″ represents:

-   -   the aliphatic hydrocarbon chain of a fatty alcohol containing        from 10 to 34 carbon atoms, preferably from 12 to 26 carbon        atoms, and particularly preferably from 16 to 22 carbon atoms;    -   said aliphatic hydrocarbon chain being linear or branched,        advantageously linear, saturated or unsaturated, preferably with        a maximum of 6 unsaturations; or    -   a mono- or polyhydroxylated, and/or mono- or polymethoxylated,        and/or mono- or polyoxidized, and/or mono- or poly-epoxylated        chain.

In other words, the invention relates to a method for preparing a fattyalcohol-enriched wax (activated wax), said method comprising thefollowing steps:

-   -   i′) mixing a wax with water or with a saline solution preferably        containing a divalent ion, such as a calcium or magnesium ion,        in a volume ratio of water or saline solution/wax comprised of        between about 0.005 and about 0.5 (preferably between 0.005 and        0.5), preferably between about 0.01 and about 0.4 (preferably        between 0.01 and 0.4),    -   ii′) keeping this mixture under agitation until an emulsion is        obtained between the wax and the water at a temperature        comprised of between about 30° C. and about 70° C. (preferably        between 30° C. and 70° C.) advantageously at about 50° C.        (preferably at 50° C.), preferably during a time period        comprised of between, advantageously about 1 to 30 minutes        (preferably 1 to 30 minutes), preferably between about 5 to        about 20 minutes (preferably between 5 and 20 minutes), and        preferably about 10 minutes (preferably 10 minutes),    -   iii′) still under agitation and at said temperature, bringing        into contact the mixture obtained in the preceding step with a        given volume of the water-insoluble fraction of Carica papaya        sap, enriched with Carica papaya lipase, obtained by        implementing the method for obtaining the water-insoluble        fraction of the aforesaid Carica papaya sap, in a volume ratio        of the water-insoluble fraction of Carica papaya sap/wax used        from about 0.01 to about 0.2 (preferably between 0.01 and 0.2),        advantageously between about 0.05 and 0.015 (preferably between        0.05 and 0.015), preferably about 0.1 (preferably 0.1), iv′)        maintaining said temperature and agitation for a time period        comprised of between about one hour and about six hours        (preferably between one hour and six hours), advantageously        between about two hours and about five hours (preferably between        two hours and five hours), preferably for about four hours        (preferably four hours), to obtain the wax enriched in fatty        alcohols.

Preferably, this method comprises, after step iv′), the following step:

-   -   v′) filtering the mixture obtained in step iv′), preferably        using at least one gradient filter or at least one superposition        of at least two filters of decreasing porosity, advantageously        from around 500 μm to around 250 μm (preferably from 500 μm to        250 μm), so as to separate said water-insoluble fraction of        Carica lipase-enriched Carica papaya sap, from the reaction        medium containing the fatty alcohol-enriched wax.

Preferably, said method comprises, after step v′), at least one of thefollowing two steps, and advantageously both:

-   -   removal of the residual water present in the reaction medium        containing the fatty alcohol-enriched wax by means of a drying        agent such as anhydrous magnesium sulphate, and/or    -   deodorizing and/or improving the shine of the fatty        alcohol-enriched wax by means of an activated carbon.

For the purposes of this invention, the wax is preferably selected from:

-   -   a wax of animal origin, such as, for example, beeswax,    -   a wax of mineral origin, or, preferably,    -   a wax of plant origin, such as jojoba wax, carnauba wax,        candelilla wax, or a mixture(s) thereof;

said wax being advantageously jojoba wax.

In a particularly important embodiment, the invention also has forobject a diacylglycerol-enriched fat, obtainable by the method forpreparing a diacylglycerol-enriched fat according to the invention (seeabove). Of course, the invention also relates to adiacylglycerol-enriched fat directly obtained by the method forpreparing a diacylglycerol-enriched fat according to the invention (seeabove).

According to a preferred embodiment, said fat has a diacylglycerolcontent comprised of between about 5% and about 30% (preferably between5% and 30%), preferably between about 7% and about 18% (preferablybetween 7% and 30%), an acid index of from about 15 to about 50 mg/g(preferably from 15 to 50 mg/g) and a peroxide index from about 5 to 30mg/g (preferably from 5 to 30 mg/g), preferably less than 20 mg/g.

This diacylglycerol-enriched fat is also called “activated fat”.

As indicated above, this diacylglycerol-enriched fat (activated) is anoil of animal, plant and/or marine origin, virgin or refined,advantageously virgin, said oil being preferably of vegetable and/ormarine origin, preferably of plant origin.

In a particularly preferred embodiment, this diacylglycerol-enriched fat(activated) is an oil, preferably virgin, selected from Calophylluminophyllum oil, raspberry oil, Camellia oil, evening primrose oil,Brazil nut oil, baobab oil and olive oil, or a mixture of at least twoof these oils; said oil, preferably virgin, being advantageouslyselected from Calophyllum inophyllum oil, raspberry oil, Camellia oil,evening primrose oil, Brazil nut oil and baobab oil or a mixture of atleast two of these oils; particularly preferably said fat beingCalophyllum inophyllum oil, preferably virgin Calophyllum inophyllumoil. Indeed, the Applicant has discovered that these (preferably virgin)diacylglycerol-enriched oils, and preferably 1,2 diacylglycerols, haveparticularly advantageous cosmetic properties when administered bycutaneous application. This is why the invention extends more broadly toa diacylglycerol-enriched oil (activated oil), advantageously 1,2diacylglycerols, as defined above, independently from the method forenrichment with diacylglycerols used to produce the activated oil.

Another object of the invention relates to a fatty alcohol-enriched wax(activated wax), capable of being obtained by the method for preparing afatty alcohol-enriched wax above. Naturally, the invention also relatesto a fatty alcohol-enriched wax (activated wax), directly obtained bythe method for preparing a fatty alcohol-enriched wax above.

The invention also has for object a cosmetic composition comprising,consisting essentially of or consisting of:

-   -   at least one diacylglycerol-enriched fat as mentioned above in        an amount representing from 10⁻⁶% to 20% of the total weight of        the composition, preferably in an amount representing from 10⁻⁴%        to 10%, preferably in an amount representing from 10⁻³% to 2%,        preferably from 0.01% to 5%, even more preferentially from 0.5        to 2.5% of the total weight of the final composition and    -   at least one physiologically acceptable excipient.

The invention also has for object a cosmetic composition comprising,consisting essentially of, or consisting of:

-   -   at least one fatty alcohol-enriched wax as mentioned above, in        an amount representing from 10⁻⁶% to 10% of the total weight of        the composition, preferably in an amount representing from 10⁻⁴%        to 1%, preferably 0.01% % to 3%, even more preferably from 0.1        to 2.0% of the total weight of the final composition and    -   at least one physiologically acceptable excipient.

In a particularly significant embodiment, the invention also has forobject a cosmetic composition comprising, consisting essentially of, orconsisting of, a mixture of at least one diacylglycerol-enriched fat asmentioned above and at least one fatty alcohol-enriched wax as mentionedabove, advantageously in a ratio by weight of fatty alcohol-enrichedwax/diacylglycerol-enriched fat comprised of between 0.01 and 0.11,preferably between 0.02 and 0.08, and preferably about 0.03 (preferably0.03).

The invention also has for object a cosmetic composition comprising,consisting essentially of, or consisting of:

-   -   a mixture of at least one diacylglycerol-enriched fat as        mentioned above and at least one fatty alcohol-enriched wax as        mentioned above, advantageously in a weight ratio of fatty        alcohol-enriched wax/diacylglycerol-enriched fat comprised of        between 0.01 and 0.11, preferably between 0.02 and 0.08, and        preferably about 0.03 (preferably 0.03), and    -   at least one physiologically acceptable excipient.

The invention also has for object a cosmetic composition comprising,consisting essentially of, or consisting of:

-   -   a mixture of at least one diacylglycerol-enriched fat as        mentioned above and at least one fatty alcohol-enriched wax as        mentioned above, in an amount representing from 10⁻⁶% to 20% of        the total weight of the composition preferably in an amount        representing from 10⁻⁴% to 10%, preferably from 0.01% to 5%,        even more preferentially from 0.5 to 2.5% of the total weight of        the final composition and    -   at least one physiologically acceptable excipient.

The composition according to the invention may be applied by anyappropriate route, in particular oral, or externally topical, and theformulation of the compositions will be adapted by the man skilled inthe art.

Preferably, the compositions according to the invention are in a formsuitable for topical application. These compositions must thereforecontain a physiologically acceptable medium, that is to say, compatiblewith the skin and its appendages, without risk of discomfort duringtheir application and covering all suitable cosmetic forms.

By topical application, it is meant to the application or spreading ofthe composition according to the invention on the surface of the skin ormucosa.

In the context of the invention, a physiologically acceptable excipientdesignates a vehicle suitable for contact with the outer layers of theskin or its appendages, that is to say which does not exhibit toxicityand does not cause irritation, undue allergic response or intolerancereaction. A physiologically acceptable excipient may comprise one ormore compounds.

As a physiologically acceptable excipient commonly used in the intendedfield of application, mention may be made, for example, of adjuvantsnecessary for the formulation, such as solvents, thickeners, diluents,antioxidants, dyes, sunscreens, self-tanning agents, pigments, fillers,preservatives, perfumes, odor absorbers, essential oils, vitamins,essential fatty acids, surfactants, film-forming polymers, etc.

In all cases, the man skilled in the art will ensure that theseadjuvants and their proportions are chosen in such a way as not to harmthe desirable advantageous properties of the composition according tothe invention.

A physiologically acceptable excipient may comprise one or morecompounds.

The compositions for the implementation of the invention may be notablyin the form of an aqueous, aqueous-alcoholic or oily solution, of anoil-in-water emulsion, water-in-oil or multiple emulsions; they may alsobe in the form of suspensions or even powders, suitable for applicationto the skin, mucous membranes, lips and/or hair.

These compositions may be more or less fluid and may also have theappearance of a cream, a lotion, a milk, a serum, an ointment, a gel, apaste or a foam. They can also be in solid form, as a stick or may beapplied to the skin in the form of an aerosol.

As a physiologically acceptable excipient commonly used in the intendedfield of application, mention may be made, for example, of adjuvantsnecessary for the formulation, such as solvents, thickeners, diluents,antioxidants, dyes, sunscreens, self-tanning agents, pigments, fillers,preservatives, perfumes, odor absorbers, essential oils, vitamins,essential fatty acids, surfactants, film-forming polymers, etc.

In all cases, the man skilled in the art will ensure that theseadjuvants and their proportions are chosen in such a way as not to harmthe desirable advantageous properties of the composition according tothe invention. These adjuvants may, for example, correspond to 0.01 to20% of the total weight of the composition. When the compositionaccording to the invention is an emulsion, the fatty phase can representfrom 5 to 80% by weight and preferably from 5 to 50% by weight relativeto the total weight of the composition. The emulsifiers andco-emulsifiers used in the composition are chosen from thoseconventionally used in the field under consideration. For example, theycan be used in a proportion ranging from 0.3 to 30% by weight, relativeto the total weight of the composition.

According to another advantageous embodiment of the invention, theactive ingredient according to the invention can be encapsulated orincluded in a cosmetic vector such as liposomes or any other nanocapsuleor microcapsule used in the field of cosmetics or adsorbed on powderedorganic polymers, mineral supports like talcs and bentonites.

Advantageously, the composition according to the invention may comprise,in addition to the active ingredient according to the invention, atleast one other active ingredient having cosmetic effects similar and/orcomplementary to those of the invention. According to the invention,this active ingredient is defined as an “additional active ingredient”.

For example, the additional active ingredient(s) may be chosen from:anti-aging, firming, lightening, moisturizing, draining,microcirculation promoting agents, pharmaceutical agents, exfoliants,desquamative agents, that stimulate the extracellular matrix, activatingenergy metabolism, antibacterial, antifungal, soothing, anti-freeradicals, anti-UV, anti-acne, anti-inflammatory, anesthetic agents, thatprovide a feeling of warmth, and a feeling of freshness and slimming.

Such additional agents may be selected from the groups comprising:

-   -   vitamin A and in particular retinoic acid, retinol, retinol        propionate, and retinol palmitate;    -   vitamin B3 and more particularly niacinamide, tocopherol        nicotinate;    -   vitamin B5, vitamin B6, vitamin B12, panthenol;    -   vitamin C, in particular ascorbic acid, ascorbyl glucoside,        ascorbyl tetrapalmitate, magnesium and sodium ascorbyl        phosphate;    -   vitamins E, F, H, K, PP, coenzyme Q10;    -   metalloproteinase inhibitors, or an activator of TIMPs;    -   DHEA, its precursors and derivatives;    -   amino acids such as arginine, ornithine, hydroxyproline,        hydroxyproline dipalmitate, palmitoylglycine, hydroxylysine,        methionine and its derivatives, N-acyl amino acid compounds;    -   natural or synthetic peptides, including di-, tri-, tetra-,        penta- and hexapeptides and their lipophilic derivatives,        isomers and complexed with other species such as a metal ion        (e.g., copper, zinc, manganese, magnesium, and others). By way        of examples, mention may be made of the peptides commercially        known under the name MATRIXYL®, ARGIRELINE®, CHRONOGEN™,        LAMINIXYL IS™, PEPTIDE Q10™, COLLAXYL™ (patent FR2827170,        ASHLAND®), PEPTIDE VINCI 01™ (patent FR2837098, ASHLAND®),        PEPTIDE VINCI 02™ (patent FR2841781, ASHLAND®), ATPeptide™        (patent FR2846883, ASHLAND®) or the synthetic peptide sequence        Arg-Gly-Ser-NH2, marketed under the name ATPeptide™ by ASHLAND®;    -   Artemia salina extract, marketed under the name GP4G™        (FR2817748, ASHLAND®);    -   plant peptide extracts such as linseed extracts (Lipigenine™,        patent FR2956818, ASHLAND®), soy bean, spelt, grapevine,        rapeseed, flax, rice, maize, and pea extracts;    -   yeast extracts, for example Dynagen™ (patent FR2951946,        ASHLAND®) or Actopontine™ (patent FR2944526, ASHLAND®);    -   dehydroacetic acid (DHA);    -   phystosterols of synthetic or natural origin;    -   salicylic acid and its derivatives, alpha- and beta-hydroxy        acids, silanols;    -   amino sugars, glucosamine, D-glucosamine, N-acetyl glucosamine,        N-acetyl-D-glucosamine, mannosamine, N-acetyl mannosamine,        galactosamine, N-acetyl galactosamine;    -   polyphenol extracts, isoflavones, flavonoids, such as grape        extracts, pine extracts, olive extracts;    -   lipids such as ceramides or phospholipids, oils of animal        origin, such as squalene or squalane; vegetable oils, such as        sweet almond, coconut, castor, jojoba, olive, rapeseed, peanut,        sunflower, wheat germ, corn germ, soy bean, cotton, alfalfa,        poppy, pumpkin, evening primrose, millet, barley, rye,        safflower, passionflower, hazelnut, palm, apricot kernel,        avocado, calendula; ethoxylated vegetable oils, and shea butter;    -   all UV screens and sunscreens;    -   cyclic AMP and its derivatives, activating agents of the        adenylate cyclase enzyme and phosphodiesterase enzyme inhibiting        agents, Centella asiatica extract, asiaticoside and asiatic        acid, methyl xanthines, theine, caffeine and its derivatives,        theophylline, theobromine, forskolin, esculin and esculoside,        ACE inhibitors, Val-Trp peptide, neuropeptide Y inhibitors,        enkephalin, extract of Gingko biloba, dioscorea extract, rutin,        yerba mate extract, guarana extract, oligosaccharides,        polysaccharides, carnitine, ivy extract, fucus extract, extract        hydrolyzed Prunella vulgaris, hydrolysed extract of Celosia        cristata, Anogeissus leiocarpus extract, Manihot utilisissima        leaf extract, palmitoylcarnitine, carnosine, taurine, elderberry        extract, seaweed extract such as Palmaria palmata extract.

The object of the invention is also the cosmetic use of an effectiveamount of at least one diacylglycerol-enriched fat according to theinvention, of at least one fatty alcohol-enriched wax according to theinvention, or of a composition according to the invention, by cutaneousapplication, to:

-   -   delay the appearance or limit the signs of skin aging, and/or    -   protect the skin and/or its appendages against all types of        external aggressions, and/or    -   promote epidermal differentiation, and/or    -   strengthen the barrier function of the skin and/or its        appendages, in a healthy human or animal individual (preferably        mammalian), preferably human.

“Visible signs of skin aging” means any changes in the externalappearance of the skin due to aging, such as, for example, fine linesand wrinkles, pigmentary defects such as age spots or lack of radiance,bags under the eyes, dark circles, withering, loss of elasticity,firmness and/or skin tone, but also any internal changes in the skinthat do not systematically result in a change in external appearancesuch as for example, thinning of the skin, or any internal damage to theskin resulting from environmental stresses such as pollution and UVradiation.

The skin is an organ whose upper part, the stratum corneum and thehydrolipidic film that covers it, acts as a physical barrier protectingthe external environment. This barrier role, more commonly known as“skin barrier function”, is of major importance in tissue homeostasis.However, it is known that alterations in the barrier function resultfrom external aggression by agents such as ultraviolet radiation (UVAand UVB), cold, drought, atmospheric pollution, certain chemicalsubstances, etc. Alterations in the barrier function are also observedduring aging of the skin and are due, among other things, to slowingdown and to abnormal epidermal differentiation, which may lead to anincrease in skin permeability.

The composition according to the invention makes it possible to fightagainst all these external aggressions, by favoring an optimal epidermaldifferentiation making it possible to maintain a functional histologicalstructure and physiological permeability sufficient to maintain thisessential barrier function represented by the skin.

The object of the invention is also a cosmetic treatment method fordelaying the appearance or limiting the signs of skin aging and/orcombating the cell aging phenomena at the cutaneous level and/or forprotecting the skin and/or its appendages against all types of externalaggressions and/or to promote cell differentiation at the cutaneouslevel and/or to reinforce the barrier function of the skin and/or itsappendages, consisting of applying to at least part of the skin and/orits appendages an effective amount of the composition according to theinvention, as defined above.

BRIEF DESCRIPTION OF THE FIGURES

For the sake of completeness, the experimental data obtained by theApplicant in order to characterize the water-insoluble fraction ofCarica papaya sap are presented below, within the detailed descriptionof the invention. This experimental data refer to FIGS. 1-4 , which arebriefly presented below:

FIG. 1 is an electrophoretic profile of the proteins present in thepapaya sap (1), in the water-insoluble fraction (also referred to as“non-water-soluble”) of the papaya sap (2), in the soluble fraction inwater (also referred to as “water-soluble”) of papaya sap (3),commercial papain (Fluka) (4), and proteins of a molecular weight marker(Invitrogen) (M) on 12% polyacrylamide gel;

FIG. 2 is a photograph of the Western blot made on papaya sap (1), thewater-insoluble fraction of papaya sap (2), the water-soluble fractionof papaya sap (3), and on commercial papain (4) with an antibodytargeting papain;

FIG. 3 is a 12% polyacrylamide Zymogram gel that contains 10% casein forprotease detection; the Zymogram gel upon which the papaya sap (1), thewater-insoluble fraction of papaya sap (2), the water-soluble fractionof papaya sap (3), standard papain (Sigma, Ref P4752) (5) is placed;this Zymogram gel being stained with Coomassie blue;

FIG. 4A is a Zymogram gel of a non-denaturing condition on a 14%polyacrylamide gel revealed with Coomassie blue; Zymogram gel upon whichwere placed the papaya sap (1), the water-insoluble fraction of papayasap (2), the water-soluble fraction of papaya sap (3), commercial papain(Fluka) (4), as well as a molecular weight marker (M);

FIG. 4B is a Zymogram gel in non-denaturing condition on a 14%polyacrylamide gel revealed by covering a gel composed of olive oil andVictoria blue (B); gel Zymogram upon which were placed the papaya sap(1), the water-insoluble fraction of papaya sap (2), the water-solublefraction of papaya sap (3), the commercial papain (Sigma, ref. P4752)(4), as well as a molecular weight marker (M).

FIG. 5 , for its part, is a graph showing quantification of pancytokeratin labeling of 0.5% activated oils and inactivated oils ofTamanu, Baobab, Raspberry and Evening primrose in human skin samples.

DETAILED DESCRIPTION OF THE INVENTION Definitions

Fat. Within the meaning of this invention, a fat has the definitioncommonly accepted in the State of the Art, namely a substance composedof molecules having hydrophobic properties. Fats are mainly composed oftriglycerides which are esters derived from a molecule of glycerol andthree fatty acids. The other components form what is called theunsaponifiable fraction or the “unsaponifiable”. The principal fats are:

-   -   oils which are in the liquid state at room temperature because        they are mainly composed of unsaturated fatty acids which have        low melting points;    -   fats that are pasty or solid at room temperature because they        are mostly composed of saturated fatty acids that have higher        melting points.

As indicated above, for the purposes of this invention, an oil ofanimal, vegetable and/or marine origin, virgin or refined,advantageously virgin, is used as a fat, said oil being preferably ofplant and/or marine origin, preferably of plant origin.

Fats of marine origin. The marine fats may be of animal, plant,bacterial and/or may be algae (for example micro-algae, as indicatedbelow). By way of example, mention may be made of fish oils, such asshark liver oil and cod liver oil, and algae and microalgae oils such asHaemotococcus pluvialis.

Oils of vegetable origin (or, more simply, “vegetable oils”). Accordingto a particularly preferred embodiment of the invention vegetable oilsare used, such as olive oil, rapeseed oil, soybean oil, corn oil, sweetalmond oil, andiroba oil, Silversmiths Oil, babassu oil, laurel berryoil, borage oil, broccoli oil, buriti oil, Calophyllum inophyllum oil,Camellia oil, safflower oil, blackcurrant oil, hemp oil, coconut oil,cucumber seed oil, cranberry oil, raspberry pip oil, passion fruit oilkiwi seed oil, hazelnut oil, Brazil nut oil, shea olein oil, grape seedoil, apricot kernel oil, sesame oil, rice bran oil, nutmeg seed oil,tomato seed oil, baobab oil, evening primrose oil, Camellia oil,camelina oil, milk thistle oil, grape seed oil, carrot oil, St. John'swort oil, flaxseed oil, walnut oil, pomegranate seed oil, nigella seedoil, borage oil, squash seed oil, perilla oil, green coffee bean oil,avocado oil, hibiscus oil, argan oil, safflower oil, rose hip oil,cloudberry oil, Chia (Salvia hispanica) oil. But also an oily macerateof flowers such as vanilla, St. John's wort, lily, carrot, bellis,arnica, aloe vera, calendula, prickly pear (non-exhaustive list). Asindicated above, among these vegetable oils, those found during theimplementation of the invention are preferred for their particularlyinteresting cosmetic properties, Calophyllum inophyllum oil (preferablyvirgin), raspberry oil (preferably virgin), Camellia oil (preferablyvirgin), evening primrose oil (preferably virgin), Brazil nut oil(preferably virgin), baobab oil (preferably virgin), and olive oil(preferably); with the stipulation that the first six are particularlypreferred.

Calophyllum Inophyllum Oil (Calophyllum inophyllum L.; Tamanu).Calophyllum, a tree dubbed Tamanu by the Tahitians and Fohara by theMalagasy, produces a remarkable oil for its beneficial action on theskin. It is very aromatic, and this oil is traditionally used to treatmany dermatological conditions (eczema, psoriasis, zoster . . . )

Numerous studies have shown that Calophyllum oil contains many activeingredients with disinfecting and protective properties, making this oila valuable ally for skin problems.

The saponifiable fraction is composed of linoleic acid (30-35%), oleicacid (30-35%), palmitic acid (15-20%), stearic acid (15-20%).

The unsaponifiable fraction is composed of Inophyllin A: anti-bacterial,disinfectant action; Calaustraline and inophyllolide: powerful healingand skin repair; Polyphenols: antioxidants and healing action, they alsohave a very strong action on the venous circulation; vitamin E: naturalantioxidant.

Baobab Oil (Adansonia digitata). Baobab oil is used in the Senegalesepharmacopoeia for its anti-allergic and anti-inflammatory properties. Incosmetics, this very emollient and soothing oil is particularlyeffective for dry, torn and chapped skin. Renowned for healing andregeneration, it is recommended for the burn care. The saponifiablefraction is composed of linoleic acid (22-26%), oleic acid (30-40%),palmitic acid (20-25%), stearic acid (2-6%). The unsaponifiable fractionis composed of phytosterols (including beta-sitosterol) and vitamin E.

Brazil Nut Oil (Bertholletia excelsa). The Brazil nut or Amazon nutcomes from a South American tree called: Bertholletia excelsa. Avegetable source of phospholipids, tocopherols and phytosterols, Brazilnut oil brings softness, comfort and elasticity to the skin while actingas a natural antioxidant.

The saponifiable fraction is composed of linoleic acid (40-45%), oleicacid (Omega-9) (30-35%), palmitic acid (10-15%), stearic acid (5-10%).The unsaponifiable fraction is composed of phytosterols (includingbeta-sitosterol): they maintain the structure and function of the cellmembrane and reduce inflammation; Squalenes: the main components of theskin surface, they have emollient and antioxidant properties.Tocopherols: natural vitamin E, powerful antioxidants that prevent therancidity of fatty acids and protect cells from free radical damage;Phospholipids: compounds similar to those that form cell membranes,emollient and protective properties; Selenium: trace element withantioxidant properties.

Evening Primrose Oil (Oenothera biennis). Evening primrose oil is veryrich in linoleic acid and is one of the rare oils to containgamma-linolenic acid. These essential fatty acids, reconstructors ofcell membranes, have exceptional softening, revitalizing, restructuringand anti-wrinkle properties. Also rich in vitamin E, evening primroseoil protects the skin from premature aging.

The saponifiable fraction is composed of linoleic acid (70-75%),gamma-linolenic (5-10%) oleic acid (4-8%), palmitic acid (4-8%), stearicacid (1-4%).

The unsaponifiable fraction (1.5 to 2%) is composed of phytosterols:healing and restorative action, they also reduce inflammation;triterpenes: anti-radical action, they protect the tissues fromdegeneration; Sterols including vitamin E: natural antioxidants.

Camellia Oil (Camellia sinensis L.). Camellia oil, also called green teaoil is extracted from tea tree seeds. The vegetable oil of Camellia hasnourishing, protective, softening and moisturizing properties for theskin.

The saponifiable fraction is composed of linoleic acid (5-10%), oleicacid (75-80%), palmitic acid (5-10%), stearic acid (1-5%).

The unsaponifiable fraction (1.5 to 2%) is composed of triterpenes;squalane; saponins as well as kaempferol and its glycosides: these arestrongly anti-inflammatory compounds, such as quercetin. They helpprotect the body from damage caused by inflammatory conditions.

Raspberry Oil (Rubus idaeus L.). Raspberry oil has healing propertiesthanks to its exceptional content of essential fatty acids (Omega-3 andOmega-6), it is also used to relieve itching and eczema. Raspberry oilis also known to absorb some of the UVA and UVB rays, providing lightprotection to the sun. It is rich in antioxidants and carotenoids and isalso an ideal oil for sun-care and after-sun repair.

The saponifiable fraction is composed of linoleic acid (50-55%) andalpha-linolenic acid (30-35%), oleic acid (Omega-9) (10-15%) palmiticacid (0-5%).

The unsaponifiable fraction is composed of vitamin E (about 5600 mg/kg):natural antioxidant; gallic acid: natural antioxidant; of carotenoids(beta-carotene, lutein, and cryptoxanthin): anti-radical action, theyprotect the tissues from degeneration.

Olive Oil (Olea europaea L.). The olive tree has been known formillennia for its exceptional longevity. It is also the first tree thatis quoted in the history of the world.

Obtained by cold pressing of its pulp and not of its pits, olive oil isone of the oils richest in oleic acid. Nourishing, softening andemollient, we find olive oil in the composition of traditional Aleppoand Marseille soaps.

It is an excellent healing agent, it has a significant concentration ofunsaponifiables (approximately 1 to 2%) that offer antioxidant, soothingand protective qualities against the harmful effects of weather and sun.Internally, olive oil has digestive and slightly laxative propertiesthat make it recommended for digestive disorders and especially those ofthe stomach.

The saponifiable fraction is composed of linoleic acid (15-20%), oleicacid (55-60%), palmitic acid (15-20%), stearic acid (0-5%).

The unsaponifiable fraction is composed of phenolic compounds(hydroxytyrosol): majority antioxidants; phytosterols: healing andrestorative action; squalenes: the main components of the skin surface,they have emollient and antioxidant properties, Vitamin E(alpha-tocopherol), Chlorophyll: natural antioxidants.

When the fat used for the purposes of this invention is an oil(preferred embodiment), this oil may be virgin or refined. According toa particularly preferred embodiment of the invention, at least onevirgin oil is preferably used, and preferably a virgin vegetable oil.Indeed, the technological platform developed by the Applicant has thesignificant advantage of being able to obtain virgin oils, preferablyvirgin vegetable oils, enriched with diacylglycerols and/or fattyalcohols (cosmetic active ingredients) without the need to turn torefined oils.

Virgin vegetable oils. Vegetable oils called “virgin” are pure vegetableoils, extracted solely by mechanical methods from fruits, seeds,kernels, generally by first cold expression (at a maximum temperature of60° C.) from a cultivated plant. These oils are characterized by theirunsaponifiable and saponifiable fractions. The unsaponifiable fractionis the residual fraction which is insoluble in water but soluble inorganic acids after saponification. The unsaponifiable fat content isgenerally in the range of 0.5 to 2%. It is a complex mixture comprisingsterols, hydrocarbons (squalene, . . . ), triterpenes, fatty alcohols(waxes), liposoluble pigments, vitamins, etc. The unsaponifiablefraction of vegetable oils finds applications in cosmetics for itsbiological properties. The saponifiable fraction of oils ischaracterized by fatty acids, glycerides and triglycerides. Fatty acidsare of two types, saturated fatty acids, unsaturated fatty acids(monounsaturated/MUFA or polyunsaturated/PUFA). Using these virginvegetable oils as fat is particularly preferred within the meaning ofthis invention.

Refined oils. Although, as indicated above, the use of a virgin oil, andpreferably a virgin vegetable oil is preferred in the sense of thisinvention, the latter also works very well with refined oils. For an oilto be refined, it must undergo hot pressure. With pressing that takesplace at a temperature of between 80° C. and 120° C. This produces acrude oil, which cannot be consumed as it is, it must undergo a longseries of treatments in order to eliminate unwanted tastes and colors.The degumming step involves removing the substances that contribute tothe instability and the production of foam and smoke during frying (freefatty acids, phospholipids), by stirring, with acidulated water, whichwill hydrolyze and thereby separate the substances. Then the taste isneutralized with a solution of soda. This is followed by bleaching at90° C. with bleaching earth and filtering to rid the oil of itspigments. The method ends with deodorization using low-pressure watervapor to better preserve the qualities of the oil. In this way a clear,odorless refined oil with little flavor is obtained. These oils are onlycharacterized by their saponifiable fraction, the unsaponifiablefraction being eliminated by the treatments.

The Applicant has discovered that the components of the unsaponifiablefraction, namely sterols, hydrocarbons (squalene, etc.), triterpenes,fatty alcohols (waxes), fat-soluble pigments, and vitamins(non-exhaustive list) make it possible to increase the biological(cosmetic) activity of the activated fats and compositions containingthem according to this invention. This is one of the reasons why the useof a virgin oil (preferably a virgin vegetable oil), including thisvaluable unsaponifiable fraction, is particularly preferred with respectto this invention, the technological platform constituting thisinvention being quite suitable for the enrichment/activation of a virginoil.

Activated Fat/Activated Oil. This invention aims in particular to obtaina diacylglycerol-enriched fat (preferably an oil), in particular1,2-diacylglycerols; the diacylglycerols present in the fat/oil thusenriched acting as a cosmetic active ingredients, in the context of acutaneous application. In other words, the diacylglycerol-enriched fatshave a modified structure and increased biological (cosmetic) activityat the cutaneous level. This is why the fats/oils thus enriched are alsocalled activated fats/activated oils.

Wax. A wax is an ester of ethylene glycol and two fatty acids or amonoester of fatty acid and of a long chain alcohol. The waxes may be ofanimal origin, such as beeswax, of plant origin, such as jojoba,carnauba, or candelilla wax, or of mineral origin.

The fatty alcohols are aliphatic alcohols with a long hydrocarbon chainhaving a single hydroxyl function in the terminal position. By fattyalcohol, the compounds of formula (III) is meant:

R″—OH  (III)

wherein R″ represents the aliphatic chain of a fatty alcohol. This fattyalcohol is constituted by a carbon chain comprising from 10 to 34 carbonatoms.

According to one particular embodiment of the invention, the fattyalcohols have a carbon chain whose carbon number is between 12 and 26.According to another preferred embodiment of the invention, the fattyalcohol has on its chain aliphatic between 16 and 22 carbon atoms.

Thus, these fatty alcohols will preferably be selected from the groupconsisting of saturated or unsaturated average size aliphatic chainfatty alcohols.

Furthermore, the aliphatic chain of fatty alcohols, that is to say thegroup R″, may be a linear or branched carbon chain, and/or saturated orunsaturated, the number of unsaturation being between 1 and 6. The R″group may also be a mono- or polyhydroxylated and/or mono- orpolymethoxylated and/or mono- or polyoxidized and/or mono- orpoly-epoxylated chain. It can thus be present in all the existingnatural forms.

These fatty alcohols are found in large quantities in waxes. These waxesmay be of animal origin, such as beeswax, or of plant origin, such asjojoba, carnauba, or candelilla wax, or of mineral origin.

Thus, for example, the controlled hydrolysis of jojoba oil wax(abbreviated as “jojoba wax”, a wax that makes up more than 96% ofjojoba oil) has the effect of releasing the main aliphatic fattyalcohols contained therein, which provides a mixture of fatty alcohols,of a saturated or unsaturated linear hydrocarbon chain.

In particular, the hydrolysis of the jojoba oil wax makes it possible toobtain a mixture of fatty alcohols of a high degree of purity having, intheir aliphatic chain, between 16 and 22 carbon atoms.

Jojoba oil wax is the liquid wax contained in the Jojoba seed(Simmondsia chinensis), a bushy plant native to southern Arizona andCalifornia, as well as northwestern Mexico. Jojoba seeds have an oilyield of about 50% of their weight. Jojoba oil is a mixture of ceridicesters with chains of 36 to 46 carbon atoms. Each molecule consists of afatty acid and a fatty alcohol linked by an ester bond. Jojoba oil ischaracterized by the presence of 10% oleic acid (C_(18:1)), 70% gadoleicacid (C_(20:1)), 15% erucic acid (C_(22:1)), 5% nervonic acid (C_(24:1))and associated fatty alcohols, octacosenol (C_(18:1)), eicosenol(C_(20:1)), docosenol (C_(22:1)) and tetracosenol (C_(24:1)). Thus thecontrolled hydrolysis of jojoba wax has the effect of releasing theprincipal aliphatic fatty alcohols contained therein, which provides amixture of saturated or unsaturated linear chain fatty alcohols.

Thus, for example, the controlled hydrolysis of jojoba wax (a wax thatmakes up more than 96% of oil) has the effect of releasing the principalaliphatic fatty alcohols and fatty acids contained therein, making itpossible to obtain a wax enriched in saturated and unsaturatedhydrocarbon-based fatty alcohols and fatty acids. In particular,hydrolysis of jojoba oil by this invention makes it possible to obtain afatty alcohol-enriched wax and fatty acids having between 18 and 24carbon atoms. This hydrolysis thus makes it possible to concentrate allthe active ingredients that are capable of acting on the skin.

The mixture of fatty acids and fatty alcohols according to the inventionwill preferably be obtained from a hydrolysis of the waxes present inthe jojoba oil (Simmondsia chinensis). This hydrolysis makes the releaseof the constituent fatty alcohols of this wax possible. This hydrolysismay be carried out enzymatically using a triacylglycerol hydrolase whosemain activity is to hydrolyze the ester bond in order to release analcohol and an acid. One of the particularly advantageous possibilitiesof this invention is to use the same lipase as that used for thehydrolysis of triacylglycerols.

Preferably according to the invention, the active ingredientsconstituting the association, i.e., the diacylglycerol-enriched oil anda wax enriched in fatty acids and fatty alcohols, will be of plant,marine or animal origin.

Activated Wax. This invention aims in particular to obtain a fattyalcohol-enriched wax (preferably jojoba oil wax, abbreviated “jojobawax”), as defined above. The fatty alcohols present in the wax thusenriched act as the active cosmetic ingredients, advantageously incombination with the diacylglycerols of the activated fat/oil (seeabove), in the context of a cutaneous application. In other words, thefatty alcohol-enriched wax has a modified structure and an increasedbiological (cosmetic) activity at the cutaneous level. This is why waxthus enriched is also called activated wax.

Lipase of Carica papaya. Lipases (triacylglycerol hydrolase; EC.3.1.1.3)are reversible enzymes which, in the reaction's most favorable sense,hydrolyze the glycerol esters. These enzymes can also be classified intoseveral groups, according to their different specificities: specificitywith respect to the substrate; position specificity orstereospecificity; specificity with regard to the nature of fatty acidsor typo-selectivity; positional specificity or stereospecificity. Inthis invention, stereospecific lipase of the sn3 type is used. Thislipase thus hydrolyzes the triglycerides by preferentially forming 1-2diacylglycerol. The lipase used may be of plant origin (example: Caricapapaya) or microbial (example: Penicelium cyclopium). The technologicalplatform developed by the Applicant is based on the use of Carica papayalipase (Villeneuve et al., JAOCS, 72, 6:753.1995).

Papaya (Carica papaya) is grown mainly in tropical and subtropicalregions around the world. Papaya is a member of the Caricaceae family,which belongs to the Brassicales family. The latex of Carica papaya isalready known for its endopeptidases, a rich source of cysteineincluding papain, chymopapain and caricain. These proteinases can beextracted as water soluble latex proteins. The presence of lipaseactivity has been reported by Giordani et al. Until recently, allattempts to solubilize enzymatic activity from this latex fraction havefailed. Carica papaya latex lipase (CPL) has therefore traditionallybeen considered a “naturally immobilized” biocatalyst. A dry powdercontaining lipase activity can be obtained after washing the latexparticles with water and centrifuging. The stereospecificity andtypo-selectivity of the Carica papaya latex raw sap were studied bothduring hydrolysis and during acyl transfer reactions. During thehydrolysis process, a 1,3-stereospecific activity was determined by thisbiocatalyst, with preferably a sn-3 stereo activity.

In the context of its experimental procedures, the Applicant hasdemonstrated a certain typo-selectivity of this lipase for fatty acids,this invention, under the experimental conditions described, orientingit to triacylglycerols having long chain fatty acids, of a length ofbetween 18 and 20, and having between 0 and 3 unsaturations. Indeed,tests carried out previously have shown that under the operatingconditions used in the invention, the yields for obtaining a1,2-diacylglycerol-enriched oil are greater with an oil havingpredominantly fatty acids with a chain length of between 18 and 20carbons and having unsaturations (olive oil for example) than with anoil whose saturated fatty acids have a chain length of between 8 and 10carbons respectively (caprylic/capric triglycerides—Mygliol® 812), 12and 16 carbons (animal butter), 16 and 18 carbons (palm oil). Theresults are summarized in Table 1 below.

TABLE 1 Comparison of DAG enrichment yields using the Carica papayalipase from different fats Butter Palm Enriched Oil Olive Oil Myglyol812 (Milk) Oil Acidity Index 17.5 10.2 3.2 13.6 (mg/g) 1,2 15  6.8 1 8.9 diacylglycerol Content 1,3  3  2 0  3.2 diacylglycerol Content

As indicated above, the technological platform developed by theApplicant is based on the use of Carica papaya lipase, and moreparticularly on the use of the water-insoluble fraction of its sap.However, this invention also extends, more broadly, to adiacylglycerol-enriched fat, by means of any suitable lipase (preferablyby means of a stereospecific lipase of the sn3 type, for example ofvegetable or microbial origin), advantageously with 1,2-diacylglycerols,preferably with 1,2-diacylglycerols of the formula (I) as defined above,said fat being selected from Calophyllum inophyllum oil (preferablyvirgin), raspberry oil (preferably virgin), Camellia oil (preferablyvirgin), evening primrose oil (preferably virgin), Brazil nut oil(preferably virgin) and baobab oil (preferably virgin), said fat beingCalophyllum inophyllum oil (preferably virgin). Moreover, the inventionalso extends to a composition comprising, consisting essentially of, orconsisting of, said diacylglycerol-enriched fat (advantageously1,2-diacylglycerols, preferably 1,2-diacylglycerols of the formula (I)as defined above) and a fatty alcohol-enriched wax (preferably of theformula (III) as defined above).

Carica Papaya Sap (also referred to as: “raw Carica papaya sap”). Papayasap is obtained from Carica papaya latex. The latex is collected byincising the still green fruits. The green fruit is superficially cut tocollect the white latex that solidifies upon contact with the air. It ismainly composed of proteins including endopeptidase enzymes (rawpapain=papain, chymopapains, papaya proteinase; papain being a proteinof 212 amino acids for a molecular weight of 23000 daltons), a lipase(Carica papaya lipase, called Carica papaya lipase in English; seeVilleneuve et al. JAOCS, 72, 6:753.1995), as well as sugars andvitamins.

Appendages. Appendages are visible protective products of the epidermis,characterized by intense keratinization. Hair, teeth, nails and hair areappendages.

Skin. Within the meaning of this invention, the skin is understood inthe broad sense as the body component constituting the coating of thebody and includes notably the scalp (skin of the skull covered withhair).

Characterization of Purified Papaya Sap, and More Particularly of theWater-Insoluble Fraction (Non-Water-Soluble) of this Papaya Sap

When dried papaya sap was suspended in water, the enzymes exhibiting thelipolytic and protease activities exhibited different solubilities: theproteases being soluble unlike the enzymes responsible for the lipaseactivity (Giordani et al., 1991). This property made it possible topartially separate papaya sap into two fractions (see Table 2 below).

TABLE 2 Study and characterization of the fractionation of papaya sapDry matter Proteins Total Percentage/ Total Amount/ Dry Amount/Proportion Fraction matter Fraction Raw 82% 82% 78% 64.5% Papaya SapInsoluble 19% 17% 47%   8% Fraction Soluble  7% 59% 95%   56% Fraction

The fractionation of papaya sap has been characterized by the dry mattercontent as well as the protein content of the fractions obtained, thesevalues are compared with those of the sap. The sap used has 18%moisture, its suspension is 10% in water and the separation of the twofractions by centrifugation results in the recovery of 92% of thestarting dry matter and 99.7% of the proteins initially present. Amongthese proteins, 88% are found in the water-soluble fraction and 12% inthe water-insoluble particulate fraction (see Table 2 above). In asecond step, the proteins obtained by the separation method have beencharacterized more precisely. Thus, after studying protease and lipaseenzymatic activities, it was possible to determine the molecular weightof the proteins present in these two fractions. The amount of proteinpresent in the raw sap as well as in each of the fractions wasdetermined according to the Kjeldahl method and is reported in Table 3below. Protease activity and lipolytic activity were then measured forpapaya sap as well as in water soluble and water-insoluble fractions.

TABLE 3 Specific and overall enzymatic activities of papaya sap as wellas water soluble and water insoluble fractions Proteolytic ActivityLipolytic Activity Raw Raw Papaya Soluble Insoluble Papaya SolubleInsoluble Sap Fraction Fraction Sap Fraction Fraction Enzymatic 1.5 1.350.1 0.67 Undetectable 0.66 Activity (U/mg Dry Matter) Specific 2.35 2.41.3 1.05 / 7.45 Enzymatic Activity (U/mg Protein) Purification / 1.02 // / 7.1 Factor Total Enzymatic 150 134 11 67 / 60 Activity

Suspension of papaya sap in water makes it possible to efficientlyseparate the protease activity from the lipase activity initiallycontained in the sap. Indeed, approximately 90% of the proteolyticactivity and the lipolytic activity present initially are foundrespectively in the water soluble and water insoluble fractions.

The molecular weight of proteins present in papaya sap and whose watersoluble and water insoluble fractions were determined on a 12%polyacrylamide gel under denaturing and reducing conditions. Theelectrophoretic profile thus obtained is shown in FIG. 1 . Track Mcorresponds to a molecular weight marker (Invitrogen); track 1corresponds to papaya sap; track 2 corresponds to the fraction in waterof papaya sap; track 3 corresponds to the water-soluble fraction of thispapaya sap and track 4 corresponds to the commercially purchased papain(Fluka).

Molecular weights of the main proteins observed were determined bycorrelation with those of the molecular weight marker using therepresentation log PM=f(Rf) (Rf=migration distance fromprotein/migration distance from the front of the gel).

These molecular weights are presented below, in Table 4.

TABLE 4 Molecular weights of proteins present in papaya sap. insolubleand water-soluble fractions, as well as in commercial papain. CommercialRaw Dried Insoluble Soluble Purified Papaya Sap Fraction Fraction PapainMolecular 35 23 35 35 Weight of 23 28 23 Protein 22 23 22 (kDa) 18 22 1818 15 15

Papaya sap has four major proteins of molecular weight of 18, 22, 23 and35 kDa respectively. The water insoluble fraction appears to be composedof a single protein having a molecular weight of 23 kDa. Since thewater-soluble fraction of six proteins having a molecular weight of 15,18, 22, 23, 28 and 35 kDa, the presence of a protein of 15 kDa must bedue to a hydrolysis occurring during the suspension of the papaya sap.Commercial papain, which has no lipolytic activity, is made up of thesame five protein forms as the papaya sap. The similarity between theelectrophoretic profiles is certainly due to the fact that thiscommercial extract is a mixture of papaya sap endopeptidases in the formof proenzymes and/or mature enzymes.

Based on these results, the Carica papaya lipase appears to have amolecular weight of 23 kDa. However, a protein of the same molecularweight is also present in the water-soluble fraction and the commercialpapain wherein a single protease activity has been revealed.

Characterization by Western Blot

An analysis of these same samples by Western Blot was then performed inorder to identify the molecular weight of the proteins corresponding topapain-type activities.

The antibody used, a polyclonal antibody derived from goat serum thattargets papain (Rockland, anti-Papain [Carica papaya]) mainly reveals aprotein of 35 kDa. Weaker signals are observed for proteins of molecularweight between 15 and 28 kDa.

Papain is described to have a molecular weight ranging from 21 to 23 kDa(Azarkan et al., 2003). The antibody used apparently bonded to thepropapain, the proenzyme precursor of papain possessing an N-terminalregion (134 amino acids) followed by the mature enzyme composed of 212amino acids. Indeed, this proenzyme consists of 345 amino acids (Tayloret al., 1999, Azarkan et al., 2003).

The more precise analysis of low intensity signals makes it possible toidentify the presence of a less specific binding of the antibody toproteins having a molecular weight of 28 kDa for the insoluble andwater-insoluble fractions as well as for a protein of 22 kDa for thewater-soluble fraction.

For the water-insoluble fraction, the anti-papain antibody did not bindto the protein having a molecular weight of 23 kDa. This confirms thatthis protein is not a protease of the papain type but the lipase ofCarica papaya.

Characterization by Zymogram Gel

The Zymogram gel technique makes it possible to determine the presenceof enzymes in a protein mixture by highlighting their own activity. Aspecific substrate is previously included in the polyacrylamide gel, theenzymes forming separate tracks and revealed by the same reaction arecalled isozymes.

The implementation of two Zymogram gels (lipolytic and proteolytic) wasconsidered in order to locate the presence of proteases and Caricapapaya lipase in the various extracts.

Zymogram to Reveal Proteases

The Novex Casein Zymogram Zymogram gel used is composed of a separationgel composed of 12% polyacrylamide and containing 10% casein, apotential substrate for proteases. This gel is produced undernon-reducing conditions in order to preserve enzymatic activities.Enzymes with proteolytic activity will locally hydrolyze the gel casein.After staining the gel with Coomassie blue, the zones where the proteinshave been hydrolyzed are highlighted by their white color on a uniformblue background, as shown in FIG. 3 . In this FIG. 3 , the track 1corresponds to the papaya sap, track 2 corresponds to thewater-insoluble fraction of papaya sap, track 3 corresponds to thewater-soluble fraction of the papaya sap and track 4 corresponds to thecommercially purchased papain (Fluka).

The hydrolysis of casein, and therefore the presence of a more or lessimportant protease activity, is observed for all the fractions analyzed(FIG. 3 ). Two isoforms are observed, isoform 2 having a greaterintensity for the water-soluble fraction and the commercial papain.

Zymogram to Reveal Lipases

The production of Zymograms for detecting lipase enzyme activity is morecomplex than for proteases. The literature describes a system consistingof two gels, a first one wherein the proteins are separated and a secondcontaining the substrate (Gilbert et al., 1991, Abousalham et al.,2000). In a first step, the proteins migrate on a polyacrylamide gelunder native conditions. Then, the presence of lipases is revealed byapplying an overlayer composed of a second polyacrylamide gel containingboth the lipid substrate and a colored indicator, Victoria Blue, thecolor of which is blue in an acid medium and red in basic medium (Yadavet al., 1997). In this type of Zymogram, the presence of lipase activityis therefore displayed by the appearance of a blue color correspondingto the hydrolysis zones of the triacylglycerols of olive oil, andtherefore to the production of oleic acid.

Two polyacrylamide gels are implemented in parallel. A first control gelis stained with Coomassie blue (FIG. 4A) and makes it possible todisplay the migration profile of the proteins in a non-denaturingcondition. In parallel, a second Zymogram gel is revealed with theoverlayer containing the substrate (see FIG. 4B).

More specifically, FIG. 4A represents a Zymogram gel in non-denaturingcondition on 14% polyacrylamide gel, revealed in Coomassie blue, andFIG. 4B represents a gel, in non-denaturing condition, on 14%polyacrylamide gel, revealed by covering a gel composed of olive oil andVictoria Blue (B).

The tracks for the Zymogram gels which are the objects of FIGS. 4A and4B are identical and correspond to:

-   -   papaya sap for track 1,    -   the water-insoluble fraction of papaya sap for track 2,    -   the water-soluble fraction of papaya sap for track 3,    -   commercially purchased papain (Fluka) for track 4, and    -   to a molecular weight marker for the track (M).

Under non-denaturing conditions, the migration is not precise and onlytwo protein entities are observed. (FIG. 4A).

With regard to the Zymogram itself, a blue coloration of the gelcorresponding to an oleic acid production is observed for the papaya sapas well as for its water-insoluble fraction. Lipolytic activity ispresent only in these fractions.

Commercial papain has no lipase activity. The 23 kDa protein present inthis extract therefore does not correspond to a lipase as the study ofthe enzymatic activities of the various fractions had already suggested(see FIG. 2 above).

This Zymogram study makes it possible to reveal proteolytic andlipolytic activity has confirmed that the papaya endopeptidases are agroup of proteins with significant proteolytic enzymatic activity in theextracts studied.

This study also demonstrated that only papaya sap and itswater-insoluble fraction have lipolytic activity that is bound to aprotein of a molecular weight close to 23 kDa.

GPC (Gas Chromatography) Method Used to Quantify 1,2-Diacylglycerol

The assay is performed by gas chromatography using an internal standard,1,3-dipalmitine. The analysis is carried out on an apolar type capillarycolumn (HP5 (30 m×0.25 mm×0.25 mm), using Agilent 7890 gaschromatography controlled by ChemStation® software and having a flameionization detector and an automatic injector.

The vector gas being helium (1.0 ml/min), the injector and the detectorbeing heated to 330° C., the oven being programmed in isotherm at 325°C. for 30 minutes. The volume of sample injected being 1 μl. Under theseconditions, 1,3-dipalmitine has a retention time of 13 minutes,respectively. The various diacylglycerols possess a retention timedetermined by the use of standards, previous bibliographic studies aswell as preliminary analyzes carried out by gas chromatography coupledwith mass spectrometry.

Determination of response coefficients, the working hypothesis beingthat all 1,2-diacylglycerols have the same response coefficient as1,2-diolein, 1,2-diolein is used as the reference molecule.

Standard solutions: prepare four solutions as follows by weighingexactly the following masses:

TABLE 5 Preparation of standard solutions Product Solution 1 Solution 2Solution 3 Solution 4 1,3-dipalmitine 20 mg 20 mg 10 mg 10 mg1,2-diolein 20 mg 10 mg 20 mg 10 mg Pyridine 500 μL HMDS 400 μL TFA 50μL

Under our analysis conditions, the response coefficient of 1,2-dioleinis 1.2315 (with a CV of 1.63%).

The enriched oil is then analyzed as follows:

TABLE 6 Enriched Oil Analysis Product Solution 5 Solution 61,2-Diacylglycerol- 100 mg 100 mg Enriched Oil 1,3-dipalmitine  15 mg 15 mg Pyridine 500 μL HMDS 400 μL TFA 50 μL

The amount of 1,2-diacylglycerol contained in the solution is thendetermined as follows: Calculation of the mass of 1,2-diolein containedin the solution:

m(Ech)=[α(Ech)×A(Ech)×m(SI)]/A(SI)

With: m=mass (in mg)

A=area under the peak

α=Response coefficient

Ech=sample (1,2-diacylglycerols)

SI=internal standard (1,3-dipalmitine)

Or:

m(1,2-diacylglycerols)=[1,2315×ΣA(1,2-diacylglycerols)×m(1,3-dipalmitine)]/A(1,3-dipalmitine)

Calculation of content: Content (%)=[m(1,2-diacylglycerols)/m(enrichedoil)]×100

Example 1—Method for Obtaining the Water-Insoluble Fraction of Caricapapaya Sap, Enriched with the Lipase of Carica papaya

The lipase-enriched Carica papaya extract is obtained by producing asuspension of 100 g of dried raw papaya sap in 900 g of distilled water.The dried raw papaya sap is thus a biphasic suspension comprisingsuspended particles and a water-soluble fraction.

The mixture is agitated with an anchor-type agitator at a speed of 500rotations per minute (rpm) for 2 hours at room temperature.

The water-insoluble (non-water-soluble) fraction of papaya sap (ascharacterized above) is separated from the soluble fraction bycentrifugation of the mixture using a centrifuge, such as a platecentrifuge with a flow rate of 200 liters per hour, for 30 minutes.

The centrifugation pellet has the fraction of interest, i.e., thewater-insoluble fraction of the raw papaya sap.

20 g of particulate fraction is thus obtained having a dry weight of25%.

Example 2—Method for Preparing an Activated 1,2-Diacylglycerol-EnrichedOil

The mixture is prepared in two separate steps, then bringing togetherthe products from these two methods in appropriate proportions, bysimple mixing.

The 1,2-diacylglycerol-enriched oil is prepared from virgin CalophyllumInophyllum or Raspberry or Baobab or Evening Primrose or Brazil Nut orCamellia oil (because they offer excellent cutaneous cosmetic propertieswhen they are activated, within the meaning of this invention) and anamount of water or saline solution containing a bivalent ion (such as acalcium or magnesium ion), representing from 0.5 to 50%, and preferablyfrom 1 to 40%, of the volume of the oil. In a thermostaticallycontrolled tank, this mixture is maintained at a temperature of between30 and 70° C., preferably at a temperature of 50° C. This mixture ismaintained under agitation using stator rotor type equipment in order toallow the formation of an emulsion between the oil and the water.

This mixture then remains under agitation in the presence of a givenvolume of the water-insoluble fraction of the Carica papayalipase-enriched Carica papaya sap, obtained by implementing the methodof Example 1, in a volume ratio water-insoluble fraction of Caricapapaya sap/fat used comprised of between about 0.01 and about 0.2,advantageously between about 0.05 and 0.015, preferably about 0.1.

The agitation and the temperature are maintained for a period of betweenone and six hours (preferably four hours), that is to say for a timesufficient to maximize the amount of diacylglycerols formed.

Monitoring of the reaction is carried out by determining theconventional fat industry indicators (measurement of the acidity indexNF EN ISO 660 and peroxide index NF ISO 3976), and by the use ofchromatographic methods, notably by gas chromatography for qualifyingand quantifying the diacylglycerol content.

The reaction medium is then purified by physicochemical purificationtechniques, the goal being to obtain a glossy, odorless1,2-diacylglycerol-enriched oil that has a color closest to the oilinitially used for the reaction.

The reaction medium is first filtered through a series of cellulosefilters of decreasing porosity (500 to 250 μm). This initially allowsthe emulsion to breakdown and second to clarify the medium.

The residual water is then removed using an anhydrous magnesium sulfatedesiccant. The oil thus obtained is then deodorized and rendered glossywith the help of an activated carbon (preferably CN1 type Cabot Norit®activated carbon).

The characteristics of the oil thus obtained has a common part inherentin the method described in the invention but also specificcharacteristics intrinsic to the nature of the oil used. The reactionmedium mainly consists of unprocessed triglycerides, monoglycerides and1,2- and 1,3-type diacylglycerols.

The oils are commonly characterized by an acidity index of between 15and 50, a peroxide index of between 5 and 30 and a 1,2-diacylglycerolrate of between 5 and 30%.

The nature of the diacylglycerols obtained is based on thetriacylglycerols initially present in the oil.

Tables 7 and 8 below make it possible to compare the acidity index, theperoxide index and the content of the 1,2-diacylglycerols and the1,3-diacylglycerols of:

six virgin oils, particularly preferred in the sense of this invention,with

the same six virgin 1,2-diacylglycerol-enriched oils.

TABLE 7 Acidity Index, Peroxide Index, and 1,2-Diacylglycerol and1,3-Diacylglycerol Content of the Six Preferred Virgin Oils EveningBrazil Initial Raspberry Baobab Primrose Nut Camellia Calophyllum VirginOil Oil Oil Oil Oil Oil Inophyllum Oil Acidity 4 5 4 3 5 20 Index (mg/g)Peroxide 15 14 10 14 12 8 Index (meq O₂/Kg) 1,2 0.5 0 0 0 0.3 2diacylglycerol Content 1,3 0.5 0 0 0 0.4 1 diacylglycerol Content

TABLE 8 Acidity Index, Peroxide Index, and 1,2-Diacylglycerol and1,3-Diacylglycerol Content of the Six Preferred Virgin Oils, afterEnrichment with 1,2 DAG 1,2 DAG 1,2 DAG 1,2 DAG 1,2 DAG 1,2 DAG 1,2 DAGEnriched- Enriched- Enriched- Enriched- Enriched- Enriched- CalophyllumOil After Raspberry Baobab Evening Brazil Camellia Inophyllum EnrichmentOil Oil Primrose Oil Nut Oil Oil Oil Acidity 21.8 27.1 21.6 18.2 22.348.6 Index (mg/g) Peroxide 29.6 2.5 25.8 18.7 12.9 4.2 Index (meq 0₂/Kg)1,2 12 16 16.9 17.7 18 8 diacylglycerol Content 1,3 2 3.5 2.5 2 2 1.5diacylglycerol Content

Furthermore, a liquid fatty alcohol-enriched wax is prepared byimplementing mutatis mutandis the preparation method described above,namely by using a wax instead of an oil and obtaining a fattyalcohol-enriched wax. For the sake of completeness, this method isdescribed below:

Firstly jojoba wax is emulsified using a stator rotor type agitator, bymixing said wax with a quantity of water or saline solution containing adivalent ion such as a calcium or magnesium ion, representing from 0.5to 50%, and preferably from 1 to 40% of the volume of wax, without pHmodification. In a thermostatically controlled tank, this mixture ismaintained at a temperature of between 30 and 70° C., preferably at atemperature of 50° C. This mixture is maintained under agitation using astator rotor type equipment to allow the formation of a stable emulsionbetween the wax and the water.

This mixture then remains under agitation in the presence of a givenvolume of the water-insoluble fraction of the Carica papayalipase-enriched Carica papaya sap, obtained by implementing the methodof Example 1, in a volume ratio water-insoluble fraction of Caricapapaya sap/fat used comprised of between about 0.01 and about 0.2,advantageously between about 0.05 and 0.015, preferably about 0.1.

The agitation and the temperature are maintained for a period of betweenone and six hours (preferably six hours), that is to say for a timesufficient to maximize the amount of fatty alcohols formed.

The reaction medium is first filtered through a series of cellulosefilters of decreasing porosity (500 to 250 μm). This initially allowsthe emulsion to breakdown and second allows the medium to clarify.

The residual water is then removed using an anhydrous magnesium sulfatedesiccant. The wax thus obtained is then deodorized and rendered glossywith the help of an activated carbon (preferably CN1 type Cabot Norit®activated carbon).

The reaction product is carried out by measuring the acidity index NF ENISO 660 and by using chromatographic methods, notably by gaschromatography which makes it possible to qualify and quantify thecontent of fatty acids and fatty alcohols.

The product obtained is preferably characterized by a fatty alcoholcontent of between 2 and 4%, and an acidity index of 5 mg/g of wax.

In a particular embodiment of the invention, the composition correspondsto a 1,2-diacylglycerol-enriched oil (activated oil) or a mixture ofseveral 1,2-diacylglycerol-enriched oils (activated oils).

In a particular embodiment of the invention, the composition correspondsto a fatty alcohol-enriched liquid wax (activated wax) or a mixture ofseveral fatty alcohol-enriched liquid waxes (activated waxes).

In a preferred embodiment, the composition according to the invention isthen obtained by simply mixing the 1,2-diacylglycerol-enriched oil(activated oil) and the fatty alcohol-enriched liquid wax (activatedwax) in weight proportions comprised of between 100 and 90% of enrichedoil and 0 to 10% enriched liquid wax.

Example 3 Cosmetic Formulations Including Activated Oil

3.1—Eye Contour Gel

TABLE 9 Composition of an “Eve Contour” gel according to the inventionBUSINESS NAME/ % INGREDIENTS INCI NAME w/w Phase A Purified WaterWater/Aqua Qs 100 Activated tamanu (Proposed) Hydrolyzed Calophyllum1.50 oil/activated Inophyllum Seed Oil and Hydrolyzed jojoba wax blendJojoba Esters according to Example 2 Flexithix ™ PVP 3.00 polymer PhaseB Si-Tec ™ DM 350 Dimethicone 3.00 silicones Si-Tec ™ RE-100Cyclopentasiloxane (and) 10.00 silicones Dimethicone/Vinyltrimethylsiloxysilicate Crosspolymer CyclopentasiloxaneCyclopentasiloxane 5.00 Phase C Liquid germall Propylene glycol (and)Diazolidinyl 0.50 plus preservative urea (and) Iodopropynylbutylcarbamate BPD-500 HDI/Trimethylol hexyllactone 0.50 crosspolymer &Silica Total 100.00 Properties: Appearance: Smooth, semi-transparent gelpH: 5.50-6.0 Viscosity (D0) 15000-25000 (Brookfield RVT/Spindle B/5RPM/1 minute/25^(o) C.)

This formula underwent a 3-month accelerated stability test in thelaboratory. The preservation of this formula has been validated by adouble efficacy test over 28 days. However, the preservatives have notbeen optimized to their lowest level of efficiency.

3.2—Biphasic Facial Serum

TABLE 10 Composition of a biphasic facial serum according to theinvention Properties: BUSINESS NAME/ % INGREDIENTS INCI NAME w/w Phase APurified Water Water/Aqua Qs 100 Phase B Blanose ™ 7H3SF CMCCarboxymethylcellulose 0.30 Zemea* Propanediol 1.00 Phase CRokonsal ™/Liquapar ™ Phenoxyethanol (and) 0.70 MEP preservativeMethylparaben (and) Ethylparaben (and) Propylparaben Neomatrix ™biofunctional Water/Aqua (and) Glycerin 1.00 (and) Pentapeptide(proposed name) Sodium Chloride Sodium Chloride 1.00 Unicert* Blue05601-J Water/Aqua (and) CI 42090 0.20 (sol. 0.1%) (FD & C Blue No. 1)Unicert* Yellow 08005-J Water/Aqua (and) CI 19140 0.60 (sol 0.1%) (FD &C Yellow No. 5) Phase D Ceraphyl ™ ODS ester Octyldodecyl Stearate 7.00Unicert* Green K7016-J CI 61565 (D & C Green No. 6) 0.006 Phase EOptiphen ™ preservative Phenoxyethanol (and) Caprylyl 0.50 GlycolCeraphyl ™ 375 ester Isostearyl Neopentanoate 3.00 Activated tamanu(Proposed) Hydrolyzed 2.50 oil/activated jojoba wax CalophyllumInophyllum Seed blend according to Example 2 Oil and Hydrolyzed JojobaEsters Smart* 5 Isododecane (and) 8.00 Hydrogenatedtetradecenyl/methylpentadecene DC* FZ-3196 Caprylyl Methicone 5.00 PFAbsolute Perfection Parfum/Fragrance (and) Linalool 0.10 Total 100.00Properties: Appearance: Green and dark blue biphasic liquid-shake beforeuse pH: 5.0-6.0 Viscosity (D0) N.A.

This formula underwent a 3-month accelerated stability test in thelaboratory. The preservation of this formula has been validated by adouble efficacy test over 28 days. However, the preservatives have notbeen optimized to their lowest level of efficiency.

Example 4—Study of the Expression of Cytokeratin in Ex Vivo Human Skin,in the Presence of Different Activated Oils According to the Invention4.1—Introduction to Cytokeratins

Cytokeratins are proteins of the intermediate filaments, which togetherwith other proteins form the cytoskeleton of the cells. These have manyfunctions including the maintenance of epithelial structure, protectionfrom injury, and communication with other cytoplasmic components(Fuertes L. et al., 2013).

They are expressed in pairs, with different expression profilesdepending on their location and are numerically ranked from 1 to 20according to their molecular weight and isoelectric point. Cytokeratinsare classified into two groups (Fuertes L. et al., 2013):

-   -   Type I cytokeratins, which are acids and generally correspond to        cytokeratins having a low molecular weight,    -   Type II cytokeratins, which are basic and generally have a high        molecular weight.

During the process of epidermal differentiation, the keratinocytes ofthe basal layer lose their proliferative potential, migrate to the upperlayers and the expression of keratins 5 and 14 is interrupted while thatof keratins 1 and 10 increases (Paladini R D et al., 1999).

4.2—Purpose of the Study

The purpose of this study is to determine the influence of variousactivated oils/activated wax blends according to the invention, obtainedby implementing the method of Example 2, on the expression ofcytokeratins in ex vivo human skin.

4.3—Oils Tested

The different oils tested are:

Activated tamanu oil (Calophyllum inophyllum)/activated jojoba wax blend(abbreviated in the rest of Example 4 as “activated tamanu oil”)obtained by the method of Example 2, versus native virgin tamanu oil,

Activated baobab oil/activated jojoba wax blend (abbreviated in the restof Example 4 as “activated baobab oil”) obtained by the method ofExample 2, versus native virgin baobab oil,

Activated raspberry oil/activated jojoba wax blend (abbreviated in therest of Example 4 as “activated raspberry oil”) obtained by the methodof Example 2, versus native virgin raspberry oil,

Activated evening primrose oil/activated jojoba wax blend (abbreviatedin the rest of Example 4 as “activated evening primrose oil”) obtainedby the method of Example 2, versus native virgin evening primrose oil.

4.3—Protocol

Human skin samples that are 6 mm in diameter are cultured in air/liquidinterface. The activated oils are diluted to 0.5% in the correspondingnon-activated oil. 20 μL of oil are applied topically to the skinsamples (only one application), then these biopsies are incubated for 24hours at 37° C. At the end of the culturing, the human skin samples areincluded in optimal cutting temperature (OCT) gel. The OCT solidifiesupon contact with the cold (liquid nitrogen). These blocks containingthe skin samples are stored at −20° C.

Then 6 μm thick sections are taken. These sections of skin samples arethen oven-dried at 37° C., and then fixed with acetone (pre-cooled to−20° C.).

Immunolabeling is performed using a pancytokeratin-specific mousemonoclonal antibody (Abcam, Ref ab27988), followed by afluorochrome-coupled anti-mouse secondary antibody (Invitrogen, RefA21202), followed by sections of skin samples are then examined under anEpi-fluorescence microscope (Zeiss Axiovert 200M). A quantification ofthe fluorescence, from the photographs obtained, was carried out withVolocity software.

4.4—Results

Microscopic observations show a significantly more intense fluorescencein the epidermis of biopsies treated with activated tamanu oil,activated baobab oil, activated raspberry oil and activated eveningprimrose oil compared to the corresponding non-activated oil. The dataobtained are presented below, in Tables 11-14.

TABLE 11 Cytokeratin Expression (%) Activated Tamanu Oil Vs. VirginTamanu Oil 0.5% Activated Virgin Tamanu Oil Tamanu Oil Cytokeratin 123.3± 4.6 100 ± 4.7 expression (%)

TABLE 12 Cytokeratin Expression (%) Activated Baobab Oil Vs. VirginBaobab Oil 0.5% Activated Virgin Baobab Oil Baobab Oil Cytokeratin 112.7± 2.6 100 ± 3.1 expression (%)

TABLE 13 Cytokeratin Expression (%) Activated Raspberry Oil Vs. VirginRaspberry Oil 0.5% Activated Virgin Raspberry Oil Raspberry OilCytokeratin 124.7 ± 2.8 100 ± 2.2 expression (%)

TABLE 14 Cytokeratin Expression (%) Activated Evening Primrose Oil Vs.Virgin Evening 0.5% Activated Virgin Evening Evening Primrose OilPrimrose Oil Cytokeratin 124.8 ± 4.6 100 ± 4.2 expression (%)

Primrose Oil

Statistical analysis was performed versus the correspondingnon-activated oil (mean±sem, n=8, ***: highly significant with Student'st-test).

In order to highlight the difference in expression observed between theactivated oils and the corresponding virgin oils, the data obtained wereplotted on the graph shown in FIG. 5 .

4.5—Conclusions

The expression of cytokeratins is increased in ex vivo human skin byactivated tamanu oil, activated baobab oil, activated raspberry oil andactivated evening primrose oil. Thus, these activated oils stimulateepidermal differentiation and therefore have interesting cosmeticproperties.

4.6—Bibliographical References

-   Fuertes L., Santonja C., Kutzner H. and Requena L.    Immunohistochemistry in Dermatopathology: a review of the most    commonly used antibodies (Part I). Actas Dermo-Sifiliográficas.    104(2):99-127 (2013)-   Paladini R. D. and Coulombe P. A. The functional diversity of    epidermal keratins revealed by the partial rescue of the keratin 14    null phenotype by keratin 16. The Journal of Cell Biology. 146    (5):1185-1201 (1999).

1. A method for enriching a fat with diacylglycerols and/or a fattyalcohol-enriched wax, the method comprising: 1) obtaining awater-insoluble fraction of Carica papaya sap, enriched with Caricapapaya lipase, by: a) suspending dried Carica papaya sap in distilledwater in a weight ratio of dried raw Carica papaya/distilled water ofbetween 0.01 and 0.5, between 0.05 and 0.25, between 0.08 and 0.2, or0.1 to create a suspension; b) stirring the suspension obtained in stepa) for a time period of between 15 minutes and 240 minutes, a timeperiod of between 30 minutes and 180 minutes, between 60 minutes and 150minutes, or 120 minutes at room temperature; c) centrifuging thesuspension obtained in step b) for a time period of between 5 minutesand 90 minutes, between 15 minutes and 60 minutes, or between 20 and 40minutes, and at a rotation speed of between 2000 and 6000 rpm, between3000 and 5000 rpm, or at 4000 rpm to obtain a pellet containing thewater-insoluble fraction of the Carica papaya sap, enriched with Caricapapaya lipase; and d) recovering the pellet containing thewater-insoluble fraction of the Carica papaya sap, enriched with Caricapapaya lipase from the suspension; and 2) providing a fat and/or wax;and 3) combining the water-insoluble fraction of the Carica papaya sap,enriched with Carica papaya lipase, from step d) to the fat and/or wax,to produce the diacylglycerol-enriched fat and/or the fattyalcohol-enriched wax.
 2. The method of claim 1, the method furthercomprising, after separating the pellet from the suspension, drying thepellet until a particulate powder of the water-insoluble fraction isproduced and then adding the particular powder to the fat and/or wax toproduce the diacylglycerol-enriched fat and/or the fattyalcohol-enriched wax.
 3. The method of claim 1, wherein the method isdirected to the preparation of diacylglycerol-enriched fats, and whereinthe method step 2) further comprises: i) mixing the fat with an amountof water or with an amount of saline solution in a volume ratio of wateror saline solution to fat of between 0.005 and 0.5, or between 0.01 and0.4 to produce an aqueous mixture; and ii) keeping the aqueous mixtureof step i) under agitation at a temperature of between 30° C. and 70°C., for a time period of between 1 and 30 minutes to produce anemulsion.
 4. The method of claim 3, wherein step 3) further comprises:iii) while still under agitation and temperature, combining the emulsionof fat and water from step ii) with a given volume of thewater-insoluble fraction of the Carica papaya sap, enriched with Caricapapaya lipase, from step d) in a volume ratio of water-insolublefraction of the Carica papaya sap to fat of between 0.01 and 0.2; andiv) maintaining the temperature and agitation for a time period ofbetween one hour to six hours, between two and five hours, or about fourhours, to obtain a mixture of the diacylglycerol-enriched fat, a portionof the water-insoluble fraction of Carica papaya sap, enriched in Caricapapaya lipase, and a reaction medium.
 5. The method of claim 4, furthercomprising: v) separating the portion of water-insoluble fraction ofCarica papaya sap, enriched in Carica papaya lipase, from the reactionmedium containing the diacylglycerol-enriched fat using at least onegradient filter or at least one superposition of at least two filters ofdecreasing porosity, from around 500 μm to around 250 μm.
 6. The methodof claim 5, wherein the method further comprises at least one of thefollowing two steps: v′) removing at least a portion of residual waterpresent in the reaction medium with a drying agent, and/or v″)deodorizing and/or improving the shine of the diacylglycerol-enrichedfat with activated carbon.
 7. The method according to claim 3, whereinthe fat is an animal, plant, and/or marine origin oil, and is virgin orrefined.
 8. The method of claim 3, wherein the fat is an oil comprisingtriglycerides with aliphatic hydrocarbon chains of a fatty acid having acarbon number of between 12 and 26, between 16 and 20, or between 16 and18; the aliphatic hydrocarbon chain being linear or branched, saturatedor unsaturated, and when unsaturated, having a number of unsaturationsof between 1 and 6, or between 1 and
 3. 9. The method of claim 3,wherein the fat is an oil comprising mono- or polyhydroxylated, and/ormono- or polymethoxylated, and/or mono- or polyoxidized, and/or mono- orpoly-epoxylated chains.
 10. The method of claim 3, wherein the fat is anoil selected from Calophyllum inophyllum oil, raspberry oil, Camelliaoil, evening primrose oil, Brazil nut oil, baobab oil and olive oil, ora mixture of at least two of these oils.
 11. The method of claim 3,wherein the diacylglycerol-enriched fat comprises diacylglycerols thatconsist of 1,2-diacylglycerols and 1,3-diacylglycerols, respectivelyrepresented by the following formulas (I) and (II):

wherein R1 and R2 are: aliphatic hydrocarbon chains of a fatty acidhaving a carbon number of between 12 and 26, between 16 and 20, orbetween 16 and 18; said aliphatic hydrocarbon chain being linear orbranched, saturated or unsaturated, and when unsaturated, with a numberof unsaturations of between 1 and 6, or between 1 and 3; or mono- orpolyhydroxylated, and/or mono- or polymethoxylated, and/or mono- orpolyoxidized, and/or mono- or poly-epoxylated chains.
 12. The method ofclaim 3, wherein the diacylglycerol-enriched fat comprisesdiacylglycerols that consist essentially of, 1,2-diacylglycerolsrepresented by the following formula (I):

wherein R1 and R2 are: aliphatic hydrocarbon chains of a fatty acidhaving a carbon number of between 12 and 26, between 16 and 20, orbetween 16 and 18; said aliphatic hydrocarbon chain being linear orbranched, saturated or unsaturated, and when unsaturated, with a numberof unsaturations of between 1 and 6, or between 1 and 3; or mono- orpolyhydroxylated, and/or mono- or polymethoxylated, and/or mono- orpolyoxidized, and/or mono- or poly-epoxylated chains.
 13. Adiacylglycerol-enriched fat made according to the method of claim 1, thediacylglycerol-enriched fat having a diacylglycerol content of between5% and 30% or between 7% and 18%, an acidity index of between 15 and 50mg/g, and a peroxide index of between 5 and 30 mg/g, or lower than 20mg/g.
 14. The method of claim 1, wherein the method is directed to thepreparation of fatty alcohol-enriched waxes; and wherein the method step2) further comprises: i) mixing the wax with an amount of water or anamount of saline solution in a volume ratio of water or saline solutionto wax of between 0.005 and 0.5, or between 0.01 and 0.4 to produce anaqueous mixture; and ii) keeping the aqueous mixture of step i) underagitation at a temperature of between 30° C. and 70° C., or at 50° C.,for a time period of between 1 and 30 minutes, between 5 and 20 minutes,or of 10 minutes, to form an emulsion.
 15. The method of claim 14,wherein step 3) further comprises: iii) while still under agitation andtemperature, combining the emulsion of fat and water from step ii) witha given volume of the water-insoluble fraction of the Carica papaya sap,enriched with Carica papaya lipase from step d) in a volume ratio ofwater-insoluble fraction of the Carica papaya sap to wax of between 0.01and 0.2, between 0.05 and 0.015, or of 0.1; and iv) maintaining thetemperature and agitation for a time period of between one hour to sixhours, between two and five hours, or four hours, to obtain a mixturecomprising the fatty-alcohol enriched wax, a portion of thewater-insoluble fraction of Carica papaya sap, enriched in Carica papayalipase, and a reaction medium; wherein the fatty-alcohol enriched waxcomprises fatty-alcohols having the formula (III):R″—OH  (III) wherein R″ represents: an aliphatic hydrocarbon chain of afatty alcohol containing from 10 to 34 carbon atoms, from 12 to 26carbon atoms, or from 16 to 22 carbon atoms; the aliphatic hydrocarbonchain being linear or branched, saturated or unsaturated, and whenunsaturated, with a maximum of 6 unsaturations; or a mono- orpoly-hydroxylated, and/or mono- or poly-methoxylated, and/or mono- orpoly-oxidized, and/or mono- or poly-epoxylated chain.
 16. The method ofclaim 15, further comprising: v) separating the portion ofwater-insoluble fraction of Carica papaya sap, enriched in Carica papayalipase, from the reaction medium containing the fatty-alcohol enrichedwax using at least one gradient filter or at least one superposition ofat least two filters of decreasing porosity, from around 500 μm toaround 250 μm.
 17. The method of claim 16, wherein the method furthercomprises at least one of the following two steps: v′) removing at leasta portion of residual water present in the reaction medium with a dryingagent, and/or v″) deodorizing and/or improving the shine of thediacylglycerol-enriched fat with activated carbon.
 18. The methodaccording to claim 14, wherein the wax is selected from a wax of animalorigin, a wax of mineral origin, a wax of plant origin, or mixturesthereof.
 19. The method according to claim 14, wherein the wax is jojobawax.
 20. A fatty alcohol-enriched wax obtained by the method accordingto claim 14, wherein the fatty alcohol content of the enriched wax isbetween 2 and 4% and the enriched wax has an acidity index of about 5mg/g of wax.
 21. A method of treating skin in a healthy human individualor animal, the method comprising cutaneous application of an effectiveamount of at least one of the diacylglycerol-enriched fats producedaccording to claim 13 and at least one of the fatty alcohol-enriched waxproduced according to claim 20, wherein the method produces a delay inappearance or a limitation of signs of skin aging, a protection of theskin and/or its appendages against external aggressions, promotion ofepidermal differentiation, and/or strengthening of a barrier function ofthe skin and/or its appendages.
 22. A composition comprising a blend ofthe diacylglycerol-enriched fat of claim 13 and at least one fattyalcohol-enriched wax according to claim 20, in a ratio by weight offatty alcohol-enriched wax to diacylglycerol-enriched fat of between0.01 and 0.11, between 0.02 and 0.08, or of 0.03.